Maze Therapeutics (MAZE) Institutional Ownership $15.05 -0.59 (-3.77%) As of 07/11/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Maze Therapeutics (NASDAQ:MAZE)Number ofInstitutional Buyers(last 12 months)26TotalInstitutional Inflows(last 12 months)$274.09MNumber ofInstitutional Sellers(last 12 months)0 Get MAZE Insider Trade Alerts Want to know when executives and insiders are buying or selling Maze Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MAZE Institutional Buying and Selling by Quarter Maze Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails6/27/2025Goldman Sachs Group Inc.13,129$145K0.0%N/A0.030% 5/29/2025Rhumbline Advisers7,235$80K0.0%N/A0.017% 5/16/2025Woodline Partners LP929,102$10.23M0.1%N/A2.121% 5/16/2025Octagon Capital Advisors LP468,000$5.15M0.6%N/A1.069% 5/16/2025Goldman Sachs Group Inc.13,129$145K0.0%N/A0.030% 5/16/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.5,135$57K0.0%N/A0.012% 5/16/2025ARCH Venture Management LLC4,120,053$45.36M22.0%N/A9.407% 5/16/2025Alyeska Investment Group L.P.125,000$1.38M0.0%N/A0.285% 5/15/2025Frazier Life Sciences Management L.P.4,129,001$45.46M2.1%N/A9.428% 5/15/2025Hhlr Advisors LTD.457,535$5.04M0.1%N/A1.045% Get the Latest News and Ratings for MAZE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/15/2025Ghisallo Capital Management LLC30,000$330K0.0%N/A0.068% 5/15/2025Driehaus Capital Management LLC132,115$1.46M0.0%N/A0.302% 5/14/2025Affinity Asset Advisors LLC250,000$2.75M0.3%N/A0.571% 5/14/2025Corebridge Financial Inc.4,328$48K0.0%N/A0.010% 5/14/2025Matrix Capital Management Company LP2,486,184$27.37M7.9%N/A5.677% 5/12/2025Nuveen LLC11,375$125K0.0%N/A0.026% 5/12/2025Invesco Ltd.20,552$226K0.0%N/A0.047% 5/9/2025Deutsche Bank AG8,885$98K0.0%N/A0.020% 5/9/2025TRV GP V LLC950,800$10.47M8.4%N/A2.171% 5/9/2025TRV GP IV LLC6,073,958$66.87M72.0%N/A13.869% 5/9/2025Charles Schwab Investment Management Inc.72,305$796K0.0%N/A0.165% 5/9/2025Harvard Management Co. Inc.637,528$7.02M0.6%N/A1.456% 5/2/2025Alphabet Inc.2,412,471$26.56M1.7%N/A5.508% 5/1/2025New York State Common Retirement Fund2,300$25K0.0%N/A0.005% 4/29/2025Bank of New York Mellon Corp17,233$190K0.0%N/A0.039% 4/23/2025Bessemer Group Inc.481,790$5.31M0.0%N/A1.100% 4/16/2025General Catalyst Group Management LLC1,035,910$11.41M1.3%N/A2.365% (Data available from 1/1/2016 forward) MAZE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MAZE shares? During the previous two years, 26 institutional investors and hedge funds held shares of Maze Therapeutics. The most heavily invested institutionals were TRV GP IV LLC ($66.87M), Frazier Life Sciences Management L.P. ($45.46M), ARCH Venture Management LLC ($45.36M), Matrix Capital Management Company LP ($27.37M), Alphabet Inc. ($26.56M), General Catalyst Group Management LLC ($11.41M), and TRV GP V LLC ($10.47M).Learn more on Maze Therapeutics' institutional investors. Which institutional investors have been buying Maze Therapeutics' stock? Of the 26 institutional investors that purchased Maze Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: TRV GP IV LLC ($6.07M), Frazier Life Sciences Management L.P. ($4.13M), ARCH Venture Management LLC ($4.12M), Matrix Capital Management Company LP ($2.49M), Alphabet Inc. ($2.41M), General Catalyst Group Management LLC ($1.04M), and TRV GP V LLC ($950.80K). How much institutional buying is happening at Maze Therapeutics? Institutional investors have bought a total of 24,895,053 shares in the last 24 months. This purchase volume represents approximately $274.09M in transactions. Related Companies Beam Therapeutics Institutional Ownership IDEAYA Biosciences Institutional Ownership Disc Medicine Institutional Ownership Belite Bio Institutional Ownership Centessa Pharmaceuticals Institutional Ownership Harmony Biosciences Institutional Ownership Adaptive Biotechnologies Institutional Ownership Sarepta Therapeutics Institutional Ownership Tarsus Pharmaceuticals Institutional Ownership Immunocore Institutional Ownership This page (NASDAQ:MAZE) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Maze Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Maze Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
